ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $378,679 | -20.2% | 63,966 | 0.0% | 0.01% | -18.2% |
| Q2 2023 | $474,628 | -21.5% | 63,966 | 0.0% | 0.01% | -31.2% |
| Q1 2023 | $604,479 | -36.2% | 63,966 | -28.1% | 0.02% | -36.0% |
| Q4 2022 | $947,488 | +44.2% | 88,966 | 0.0% | 0.02% | +38.9% |
| Q3 2022 | $657,000 | +53.5% | 88,966 | 0.0% | 0.02% | +80.0% |
| Q2 2022 | $428,000 | -5.9% | 88,966 | 0.0% | 0.01% | +11.1% |
| Q1 2022 | $455,000 | -15.0% | 88,966 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $535,000 | -23.7% | 88,966 | +12.4% | 0.01% | -23.1% |
| Q3 2021 | $701,000 | -10.6% | 79,166 | -20.2% | 0.01% | -7.1% |
| Q2 2021 | $784,000 | +21.9% | 99,166 | +17.5% | 0.01% | +16.7% |
| Q1 2021 | $643,000 | +19.7% | 84,399 | +22.5% | 0.01% | +9.1% |
| Q4 2020 | $537,000 | -17.1% | 68,899 | +3.0% | 0.01% | -26.7% |
| Q3 2020 | $648,000 | – | 66,899 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sentinus, LLC | 149,050 | $1,408,523 | 0.47% |
| Intrepid Financial Planning Group LLC | 19,000 | $179,550 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $113,400 | 0.06% |
| Interchange Capital Partners, LLC | 11,413 | $107,853 | 0.06% |
| Virtu Financial LLC | 21,650 | $205 | 0.02% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 15,000 | $141,750 | 0.02% |
| J. Goldman & Co LP | 42,228 | $399,055 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $604,479 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 46,311 | $437,639 | 0.01% |
| 683 Capital Management, LLC | 16,000 | $151,200 | 0.01% |